Related Experiment Video
Updated: Aug 18, 2026

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
[Safety of Zyban administration in nicotine dependence treatment]
Maciej L Goniewicz1, Jan Czogała
1Katedra Chemii Ogólnej i Analitycznej Slaskiej Akademii Medyczej w Sosnowcu. mgoniewicz@wp.pl
Abstract:
Zyban (bupropion hydrochloride, produced by Glaxo Wellcome Group) is a drug available in Poland used in a nicotine dependence treatment, as an aid in smoking cessation. The aim of the study was to review available information concerning observed side-effects of Zyban. The information provided by producer, articles and reports published in MEDLINE and EMBASE databases since January 2001 till September 2004 were analysed. Side-effects were analysed, compared and classified according to anatomy-physiological systems, where these side-effects are observed.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Dependence
Drug Delivery: Enteral Route
Drugs in...
Drug Abuse and Addiction: Pharmacological Phenomena
